Filing metadata

Accession number
0001600620-23-000032
Form type
Form 3
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Aug 21, 2023
Reporting period
Aug 18, 2023
Description
Initial ownership

Explore SEC Filings Hub